Overview
Natera
?
Steven Chapman
See more contacts
Medical and Diagnostic Laboratories
,
Pharmaceutical and Medicine Manufacturing
,
Ambulatory Health Care Services
,
Health Care and Social Assistance
,
Testing laboratories
See All Industries In vitro diagnostics
See Fewer Industries
See All Industries In vitro diagnostics
See Fewer Industries
Child Care Services
,
Community Food and Housing, and Emergency and Other Relief Services
,
Continuing Care Retirement Communities and Assisted Living Facilities for the Elderly
,
General Medical and Surgical Hospitals
,
Home Health Care Services
,
Individual and Family Services
,
Nursing Care Facilities (Skilled Nursing Facilities)
,
Offices of Dentists
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
View more , Offices of Other Health Practitioners , Offices of Physicians , Other Ambulatory Health Care Services , Other Residential Care Facilities , Outpatient Care Centers , Psychiatric and Substance Abuse Hospitals , Residential Intellectual and Developmental Disability, Mental Health, and Substance Abuse Facilities , Specialty (except Psychiatric and Substance Abuse) Hospitals Vocational Rehabilitation Services
View fewer
?
?
?
Modelled
?
Actual
$1.70 billion
Actual
56.75%
$1,660
DEC
?
?
NASDAQ:NTRA
Contacts
Get in Touch with 6 Principals* and 638 Contacts
-
Steven ChapmanPresident and Chief Executive Officer
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of December 31, 2024 (12 month period) in USD
Annual Revenue 2024
$1.70 billion
USD
Actual
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $136 | -$247 | -$432 |
| Net Investing Cash | $138 | $168 | $330 |
| Net Financing Cash | $30 | $254 | $483 |
| Net Change in Cash | $303 | $176 | $381 |
| Cash at Beginning of Period | $642 | $466 | $85 |
| Cash at End of Period | $946 | $642 | $466 |
| Capital Expenditure | -$77 | -$39 | -$48 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $946 | $642 | $466 |
| Accounts Receivable | $314 | $278 | $244 |
| Inventories | $45 | $41 | $35 |
| Other Current Assets | $71 | $297 | $466 |
| Asset Summary | |||
| Total Current Assets | $1,376 | $1,259 | $1,212 |
| Tangible Fixed Assets | $248 | $168 | $164 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $1,661 | $1,442 | $1,394 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $35 | $15 | $31 |
| Short-Term Debt | $80 | $80 | $80 |
| Other Current Liabilities | $229 | $212 | $199 |
| Liability Summary | |||
| Total Current Liabilities | $344 | $307 | $310 |
| Long-Term Debt | $ | $283 | $282 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $465 | $676 | $689 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$2,568 | -$2,377 | -$1,943 |
| Equity Summary | |||
| Total Equity | $1,195 | $765 | $706 |
| Shares Outstanding | 132,646,000 | 119,581,000 | 111,255,000 |